Wedge Industrial Co.,Ltd. (SZSE: 000534)
Health Care · Biotechnology · CN
CN¥21.63
-4.46% today · +35.8% 1Y
Wedge Industrial Co.,Ltd. (SZSE: 000534) operates in the Biotechnology industry within the Health Care sector. The company is valued at $1.56B and employs 1,438 people.
Over the last twelve months the share price has gained 35.8%, trading between 14.97 and 49.14.
Tweenvest scores Wedge Industrial Co.,Ltd. across four factors: quality 65/100, value 42/100, growth 59/100. Its strongest factor is quality.
000534 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.56B
- Revenue (TTM)
- $196.04M
- P/E
- 54.28
- EPS
- 0.40
- Dividend yield
- —
- Beta (5Y)
- 0.44
- 52-week high
- CN¥49.14
- 52-week low
- CN¥14.97
- Avg volume (3M)
- —
- Shares outstanding
- 482.35M
- Employees
- 1,438
- Next earnings
- —
About Wedge Industrial Co.,Ltd.
Wedge Industrial Co., Ltd., based in Shantou, China, has been in operation since its founding in 1992. The company maintains a diversified business approach, primarily engaging in the investment, development, operational management, and interior decoration of real estate assets across China. Additionally, its activities extend to the full lifecycle of microecological preparations and superalloys, encompassing their research, development, production, and market distribution. The enterprise adopted its current name in May 2013, having previously operated under the name Guangdong Wanze Industrial Co., Ltd.
- ISIN
- CNE0000004T4
- Founded
- 1992
- Listed since
- Jan 10, 1994
- Exchange
- Shenzhen Stock Exchange
- Currency
- CNY
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| COMPASS Pathways plcNasdaqGS: CMPS | $1.59B | $11.47 | -1.88% |
| Yantai Dongcheng Pharmaceutical Group Co.,Ltd.SZSE: 002675 | $1.59B | CN¥12.90 | +1.74% |
| Syndax Pharmaceuticals, Inc.NasdaqGS: SNDX | $1.57B | $16.90 | -3.98% |
| uniQure N.V.NasdaqGS: QURE | $1.56B | $22.54 | -2.59% |
| Stoke Therapeutics, Inc.NasdaqGS: STOK | $1.55B | $23.95 | -1.40% |
| Absci CorporationNasdaqGS: ABSI | $1.53B | $8.94 | -3.04% |
| GenFleet Therapeutics (Shanghai) Inc.SEHK: 2595 | $1.51B | HK$31.94 | +6.82% |
| Immunocore Holdings plcNasdaqGS: IMCR | $1.50B | $29.09 | -1.09% |
Figures last refreshed Oct 4, 2026.